{"data":[{"accessionNo":"0001950047-26-009971","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS, INC.","ticker":"SYRE","personName":"HEIDY KING-JONES","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":29335,"aggregateMarketValue":2611695.05,"unitsOutstanding":88173762,"approxSaleDate":"2026-10-01","exchange":"NASDAQ","filedAt":"2026-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-009978","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"CAMERON TURTLE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":45000,"aggregateMarketValue":4006350,"unitsOutstanding":88173762,"approxSaleDate":"2026-10-01","exchange":"NASDAQ","filedAt":"2026-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-009876","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS, INC.","ticker":"SYRE","personName":"SCOTT BURROWS","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":17500,"aggregateMarketValue":1573157.25,"unitsOutstanding":88173762,"approxSaleDate":"2026-09-30","exchange":"NASDAQ","filedAt":"2026-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-008970","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"HEIDY KING-JONES","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":46665,"aggregateMarketValue":4168584.45,"unitsOutstanding":88173762,"approxSaleDate":"2026-09-01","exchange":"NASDAQ","filedAt":"2026-09-01","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-007821","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"JEFFREY ALBERS","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":517100,"unitsOutstanding":88173762,"approxSaleDate":"2026-08-07","exchange":"NASDAQ","filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-007819","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"SESSIONS, LLC","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":18000,"aggregateMarketValue":1861560,"unitsOutstanding":88173762,"approxSaleDate":"2026-08-07","exchange":"NASDAQ","filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-007571","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"SCOTT BURROWS","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":30000,"aggregateMarketValue":2949900,"unitsOutstanding":86841253,"approxSaleDate":"2026-08-03","exchange":"NASDAQ","filedAt":"2026-08-03","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-006779","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"CAMERON TURTLE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":45000,"aggregateMarketValue":3995100,"unitsOutstanding":86841253,"approxSaleDate":"2026-07-01","exchange":"NASDAQ","filedAt":"2026-07-01","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-006485","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS, INC.","ticker":"SYRE","personName":"SCOTT BURROWS","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":15000,"aggregateMarketValue":1306980,"unitsOutstanding":86841253,"approxSaleDate":"2026-06-25","exchange":"NASDAQ","filedAt":"2026-06-25","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001104659-26-076969","issuerCik":"0001636282","issuerName":"Spyre Therapeutics, Inc.","ticker":"SYRE","personName":"Fairmount Healthcare Fund II L.P.","relationship":"Director","securityClass":"Common","broker":"Goldman Sachs & Co. LLC","unitsToSell":4684781,"aggregateMarketValue":399658667,"unitsOutstanding":86841253,"approxSaleDate":"2026-06-23","exchange":"NASDAQ","filedAt":"2026-06-23","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-006375","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS, INC.","ticker":"SYRE","personName":"MICHAEL HENDERSON","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":1766800,"unitsOutstanding":86841253,"approxSaleDate":"2026-06-22","exchange":"NASDAQ","filedAt":"2026-06-22","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-005572","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"SHELDON SLOAN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":16667,"aggregateMarketValue":1152689.72,"unitsOutstanding":86841253,"approxSaleDate":"2026-06-03","exchange":"NASDAQ","filedAt":"2026-06-03","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-004262","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS, INC.","ticker":"SYRE","personName":"MICHAEL HENDERSON","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":80000,"aggregateMarketValue":5848000,"unitsOutstanding":86841253,"approxSaleDate":"2026-05-08","exchange":"NASDAQ","filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-003923","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS, INC.","ticker":"SYRE","personName":"SHELDON SLOAN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":78333,"aggregateMarketValue":5831891.85,"unitsOutstanding":78540164,"approxSaleDate":"2026-05-01","exchange":"NASDAQ","filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-003922","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS, INC.","ticker":"SYRE","personName":"SCOTT BURROWS","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":27500,"aggregateMarketValue":2047375,"unitsOutstanding":78540164,"approxSaleDate":"2026-05-01","exchange":"NASDAQ","filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-003140","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"SHELDON SLOAN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":7958,"aggregateMarketValue":401401.52,"unitsOutstanding":78540164,"approxSaleDate":"2026-04-01","exchange":"NASDAQ","filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-002111","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"SCOTT BURROWS","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10000,"aggregateMarketValue":424900,"unitsOutstanding":78540164,"approxSaleDate":"2026-03-03","exchange":"NASDAQ","filedAt":"2026-03-03","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-26-001983","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS INC","ticker":"SYRE","personName":"CAMERON TURTLE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":60000,"aggregateMarketValue":2580600,"unitsOutstanding":78540164,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/syre"},{"accessionNo":"0001950047-25-008390","issuerCik":"0001636282","issuerName":"SPYRE THERAPEUTICS, INC.","ticker":"SYRE","personName":"CAMERON TURTLE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":90000,"aggregateMarketValue":2201400,"unitsOutstanding":60400960,"approxSaleDate":"2025-11-03","exchange":"NASDAQ","filedAt":"2025-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/syre"}],"updatedAt":"2026-10-29T10:32:50.042Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/syre","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}